Literature DB >> 20182819

Estrogen and autoimmune disease.

Sara E Walker1.   

Abstract

Estrogenic hormones possess both immunostimulating and immunosuppressive properties. In systemic lupus erythematosus (SLE), pregnancy is associated with disease flares. In some situations, exogenous estrogen predisposes to development of new SLE, flares of preexisting SLE, and thromboses in susceptible individuals. In contrast, treatment with exogenous estrogen protects postmenopausal rheumatoid arthritis (RA) patients from active RA and osteoporosis. The search for estrogen-like compounds with anti-inflammatory properties may expand treatment options in RA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20182819     DOI: 10.1007/s12016-010-8199-x

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  66 in total

1.  Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study.

Authors:  Chi Chiu Mok; Chi Hung To; Anselm Mak; Kwok Man Ma
Journal:  Arthritis Rheum       Date:  2005-12

2.  Quantitative determination of steroid hormone receptor positive cells in the synovium of patients with rheumatoid arthritis and osteoarthritis: is there a link to inflammation?

Authors:  S Capellino; B Riepl; L Rauch; P Angele; M Cutolo; R H Straub
Journal:  Ann Rheum Dis       Date:  2006-06-30       Impact factor: 19.103

3.  Lupus disease activity associated with menstrual cycle.

Authors:  A D Steinberg; B J Steinberg
Journal:  J Rheumatol       Date:  1985-08       Impact factor: 4.666

4.  The impact of hormone replacement therapy on humoral and cell-mediated immune responses in vivo in post-menopausal women with rheumatoid arthritis.

Authors:  H Forsblad d'Elia; H Carlsten
Journal:  Scand J Immunol       Date:  2008-12       Impact factor: 3.487

Review 5.  [Ovulation induction therapy and systemic lupus erythematosus].

Authors:  Du Lê Thi Huong; Bertrand Wechsler; Jean-Charles Piette
Journal:  Ann Med Interne (Paris)       Date:  2003-02

6.  Incidence of systemic lupus erythematosus. Race and gender differences.

Authors:  D J McCarty; S Manzi; T A Medsger; R Ramsey-Goldman; R E LaPorte; C K Kwoh
Journal:  Arthritis Rheum       Date:  1995-09

7.  Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis.

Authors:  C Jochems; M Lagerquist; C Håkansson; C Ohlsson; H Carlsten
Journal:  Clin Exp Immunol       Date:  2008-04-24       Impact factor: 4.330

8.  Lifespan is prolonged in autoimmune-prone (NZB/NZW) F1 mice fed a diet supplemented with indole-3-carbinol.

Authors:  Karen J Auborn; Mei Qi; Xiao J Yan; Saul Teichberg; DaZhi Chen; Michael P Madaio; Nicholas Chiorazzi
Journal:  J Nutr       Date:  2003-11       Impact factor: 4.798

9.  Effects of an aromatase inhibitor on thymus and kidney and on oestrogen receptors in female MRL/MP-lpr/lpr mice.

Authors:  B D Greenstein; Y Y Dhaher; E de F Bridges; G Keser; M A Khamashta; J Etherington; A S Greenstein; P J Coates; P A Hall; G R Hughes
Journal:  Lupus       Date:  1993-08       Impact factor: 2.911

10.  Women, autoimmunity, and cancer: a dangerous liaison between estrogen and activation-induced deaminase?

Authors:  Robert W Maul; Patricia J Gearhart
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

View more
  15 in total

Review 1.  Risk factors of systemic lupus erythematosus flares during pregnancy.

Authors:  Luis J Jara; Gabriela Medina; Pilar Cruz-Dominguez; Carmen Navarro; Olga Vera-Lastra; Miguel A Saavedra
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors.

Authors:  Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 3.  Environmental exposures, epigenetic changes and the risk of lupus.

Authors:  E C Somers; B C Richardson
Journal:  Lupus       Date:  2014-05       Impact factor: 2.911

Review 4.  Ovarian stimulation and embryo banking for fertility preservation in a woman with severe mixed connective tissue disease: Is it safe?

Authors:  Vasileios D Sioulas; Clarisa R Gracia
Journal:  J Assist Reprod Genet       Date:  2011-12-29       Impact factor: 3.412

5.  IL-6 contributes to an immune tolerance checkpoint in post germinal center B cells.

Authors:  Yi Yan; Ying-Hua Wang; Betty Diamond
Journal:  J Autoimmun       Date:  2011-12-07       Impact factor: 7.094

6.  Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy.

Authors:  Amit K Maiti; Swapan K Nath
Journal:  Autoimmun Rev       Date:  2012-09-18       Impact factor: 9.754

7.  Age-related differences in the clinical characteristics of systemic lupus erythematosus in children.

Authors:  Jia Zhu; Fengqi Wu; Xiaolan Huang
Journal:  Rheumatol Int       Date:  2012-01-07       Impact factor: 3.580

8.  Pigmented villonodular synovitis of the hip in systemic lupus erythematosus: a case report.

Authors:  Hans-Joachim Anders
Journal:  J Med Case Rep       Date:  2011-09-07

Review 9.  Endobiogeny: a global approach to systems biology (part 2 of 2).

Authors:  Jean-Claude Lapraz; Kamyar M Hedayat; Patrice Pauly
Journal:  Glob Adv Health Med       Date:  2013-03

Review 10.  Associated features in females with an FMR1 premutation.

Authors:  Anne C Wheeler; Donald B Bailey; Elizabeth Berry-Kravis; Jan Greenberg; Molly Losh; Marsha Mailick; Montserrat Milà; John M Olichney; Laia Rodriguez-Revenga; Stephanie Sherman; Leann Smith; Scott Summers; Jin-Chen Yang; Randi Hagerman
Journal:  J Neurodev Disord       Date:  2014-07-30       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.